ClinicalTrials.gov
ClinicalTrials.gov Menu

Fenretinide and Lonafarnib in Treating Patients With Advanced or Recurrent Head and Neck Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00103090
Recruitment Status : Terminated (Slow Accrual.)
First Posted : February 8, 2005
Last Update Posted : November 14, 2012
Sponsor:
Collaborator:
National Cancer Institute (NCI)
Information provided by (Responsible Party):
M.D. Anderson Cancer Center

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Actual Primary Completion Date : January 2006
  Actual Study Completion Date : November 2006